Absci Corp
ABSI
NASDAQ
Biotechnology
$9.18
USD
-0.28 (-2.96%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.62B
Volume 2.2M
Revenue
$1.56M
TTM
-62.3%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-121.08M
TTM
-6.9%
YoY
Operating Cash Flow
$-108.08M
TTM
-41.5%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.6 | 0.4 | 0.7 | 0.2 | 0.3 |
YoY Growth | -53.3% | -77.8% | -2.3% | -81.8% | -46.4% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.6 | 0.4 | 0.7 | 0.2 | 0.3 |
Selling, General & Administrative | 8.5 | 8.4 | 8.6 | 9.1 | 9.2 |
Other Operating Expenses | 0.0 | 0.0 | -5.1 | 0.0 | 0.0 |
Total Operating Expenses | 32.0 | 30.5 | 31.7 | 31.1 | 34.5 |
Operating Income | -31.4 | -30.2 | -31.0 | -30.8 | -34.2 |
EBITDA | -28.4 | -27.3 | -28.2 | -28.1 | -31.5 |
Other Income / Expense | 1.0 | 1.6 | 1.3 | 1.3 | 1.0 |
Total Other Income / Expense | 1.0 | 1.6 | 1.3 | 1.3 | 1.0 |
Income Before Income Taxes | -30.4 | -28.6 | -29.7 | -29.6 | -33.2 |
Income Taxes | 0.1 | 0.1 | -0.2 | 0.0 | 0.0 |
Net Income | -30.6 | -28.7 | -29.6 | -29.6 | -33.2 |
Consolidated Net Income / Loss | -30.6 | -28.7 | -29.6 | -29.6 | -33.2 |
Net Income Attributable to Common Shareholders | -30.6 | -28.7 | -29.6 | -29.6 | -33.2 |
Basic EPS | -$0.24 | -$0.20 | -$0.20 | -$0.19 | -$0.21 |
Diluted EPS | -$0.24 | -$0.20 | -$0.20 | -$0.19 | -$0.21 |
Basic Shares Outstanding | 127.6M | 143.8M | 151.3M | 153.0M | 157.5M |
Diluted Shares Outstanding | 127.6M | 143.8M | 151.3M | 153.0M | 157.5M |